Articles for category: Most Popular

Russ Cohen

Most Popular

‘Bond King’ Bill Gross on the Overvaluation of 10-Year US Treasury ‘Bond King’ Bill Gross on the Overvaluation of 10-Year US Treasury

Bill Gross, a renowned investor and “bond king,” has warned about the overvaluation of 10-year U.S. Treasury debt and suggested a potential alternative. The Warning: Gross, the co-founder of Pacific Investment Management Co., recently shared his views on the state of the U.S. bond market, as reported by Bloomberg. He believes that the 10-year U.S. ...

Russ Cohen

Most Popular

The Future Looks Bright: 3 High-Growth Stocks for 2024

Will 2024 be the year of growth stocks, value stocks, dividend stocks, or perhaps a blend of all three? What is certain is that quality growth stocks have a history of performing well over time. Even companies with pricy valuations in relation to their trailing earnings have the potential to become a better value if ...

Russ Cohen

Most Popular

Examining Potential January 2024 Dow Jones Stocks

The Dow Jones Industrial Average (DJIA) stands as a cornerstone of the stock market, representing a rich tapestry of economic health of the U.S. This index offers insight into the performance of the stock market, and by extension, the U.S. economy. Investing in Dow stocks can provide a strategy for individuals aiming for stability and ...

Russ Cohen

Most Popular

Berkshire Hathaway’s Prime Stock Picks for Investors Top Berkshire Hathaway Recommendations for January

Coca-Cola: A Time-Tested Staple Coca-Cola (NYSE: KO) has been a staple in Berkshire Hathaway’s portfolio since its first investment in 1988. Since then, Berkshire Hathaway has accumulated 400 million Coca-Cola shares, representing around 9% of the company’s shares. In the U.S., Coca-Cola had a 46% market share in the carbonated soft drink market at the ...

Russ Cohen

Most Popular

Why Sana Biotechnology Shares Are on the Rise Why Sana Biotechnology Shares Are on the Rise Today

Sana Biotechnology, Inc. SANA has received clearance from the U.S. Food and Drug Administration (FDA) to commence a study of SC262, marking a significant milestone for the company. The clearance for SC262, an investigational new drug (IND) application, is intended for use in patients with relapsed or refractory B-cell malignancies, particularly those who have previously undergone ...

Russ Cohen

Most Popular

Google’s Smartphone Launch Impact on Investment Google Revolutionized the Smartphone Industry with Its First Device 13 Years Ago

Alphabet Inc.’s GOOG GOOGL Google’s Android operating system dominates the global smartphone industry, thanks to a wide range of options available, starting right at $100 and going all the way up to $1,600. Android’s success has been one of the key drivers for Google’s growth – the search giant acquired Android Inc. in 2005. Founded ...

Russ Cohen

Most Popular

Nasdaq 100 Snaps Longest Negative Streak In 14 Months As Tech Stocks Find Relief On Mixed Data Nasdaq 100 Sees Silver Lining After Longest Negative Streak In 14 Months

After a turbulent week, the Nasdaq 100 Index managed to clinch a 0.15% gain, terminating a five-session losing streak – the lengthiest downturn since October 2022. The tech index saw intraday highs reaching 16,415 and lows dipping to 16,249 on Friday, marking a rollercoaster trading session. Market sentiment swung back and forth in response to ...

Russ Cohen

Most Popular

The Semiconductor Sector: A Bountiful 73% Surge in 2023 and Underappreciated Players The Semiconductor Sector: A Bountiful 73% Surge in 2023 and Underappreciated Players

To declare that 2023 stood as a banner year for semiconductor stocks would be a gross understatement. The sector, as delineated by the VanEck Semiconductor ETF (NASDAQ: SMH), catapulted an astounding 73.4% over the year! If you had steered clear of this mercurial yet critical segment of the market, you would have unwittingly forfeited a ...